Floatz logo

Allogeneic Lymphocytes

Myeloproliferative Neoplasm

Leland MethenyCell therapyPhase 1Active
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

46 Active assets in the Myeloproliferative Neoplasm cohort.

Asset / SponsorPhaseRating
Decitabine
Jacqueline Garcia, MD
Phase 2BB
Azacitidine
Prelude Therapeutics
Phase 2BB
Cytosin-Arabinosid
Fred Hutchinson Cancer Center
Phase 3BB
Cladribine
M.D. Anderson Cancer Center
Phase 2BB
Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs
Fred Hutchinson Cancer Center
Phase 2BB

View all 50 →

Same molecule, other indications

Allogeneic Lymphocytes is also rated in:

metastatic melanomaDormant
CCC
Indicative ·
48 / 100
View asset →
melanomaDormant
CCC
Indicative ·
48 / 100
View asset →
Allogeneic Stem Cell Transplant CandidateDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →